NTRK1 and B-cell chronic lymphocytic leukemia: In chronic lymphocytic leukemia (CLL), persistent stimulation of B‐cell receptors, receptor tyrosine kinases (RTKs), and subsequent cascades leads to resistance to apoptosis and improved survival of leukemic cells.